Overview


According to FutureWise analysis, the market for Next-Generation Sequencing (NGS) in 2023 is US$ 2.16 billion, and is expected to reach US$ 6 billion by 2031 at a CAGR of 13.60%.

Next Generation Sequencing (NGS) is a powerful and accessible high-throughput tool to gain insight into potentially any species at the genomic, epigenetic, or transcriptomic level. Sample preparation is preparing DNA for Next Generation Sequencing (NGS). Sample preparation differs depending on the type of material being sampled and the objective of the experiment. Different types of genetic material, such as DNA or RNA, have slightly different sample preparation methods. In addition, the various applications of NGS add another dimension. The foremost step in every sample preparation protocol is extracting the genetic material– DNA or RNA– from cells and tissues. Other molecules, such as RNA and proteins, interfere with the sequencing process and must be removed before doing anything else. The specific tissue type and storage conditions determine the details of this extraction process. Extraction entails breaking down the extracellular matrix and opening the cell membranes using enzymes, solvents, or surfactants. The DNA in the resulting mixture must then be isolated. Therefore, no preparation protocol is always optimal, and several questions need to be asked before the experiment to determine the best methods.

FutureWise Market Research has published a report that provides an insightful analysis of Next Generation Sequencing (NGS) Sample Preparation Market trends affecting overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes the stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the Next Generation Sequencing (NGS) Sample Preparation Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organization to enhance their decisions on business expansion and strategic changes for increasing customer base.

  • Agilent Technologies, Inc.
  • Becton Dickinson and Company
  • Beckman Coulter (A Subsidiary of Danaher)
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • New England Biolabs, Inc.
  • Nugen Technologies, Inc. (Part of Tecan Trading Ag)
  • Oxford Gene Technology (Part of Sysmex)
  • Oxford Nanopore
  • Technologies, Ltd.
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • QIAGEN N.V.
  • Raindance Technologies, Inc. (Part of Bio-Rad Laboratories)
  • Swift Biosciences Inc.
  • Thermo Fisher Scientific Inc.

Recent Developments in Next Generation Sequencing (NGS) Sample Preparation Market:

  • In September 2022 - Illumina Inc. launched its advanced NovaSeq X systems for next-generation sequencing. These systems have the capacity to generate more than 20,000 whole genomes per year, marking 2.5 times that of prior sequencers.
  • In August 2022 - QIAGEN expanded its range of next-generation sequencing (NGS) portfolio with the launch of QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit. These innovations have set new standards in preparing samples for determining their nucleic acid sequences

By Product & Services

  • Workstation/Instruments
  • Reagents & Consumables
  • Services

By Workflow

  • DNA Fragmentation & Library Preparation
  • Target Enrichment
  • QC

By Sample Type

  • DNA
  • RNA

By Method

  • Manual Sample Preparartion
  • Microfluidic Sample Preparation
  • Automated Liquid Handling-based Sample Preparation

By Application

  • Diagnostics
  • Drug Discovery
  • Agricultural & Animal Research
  • Others

By End User

  • Academic Institutes & Research Centers
  • Hospitals & Clinics
  • Pharma & Biotech Companies
  • Other End-users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The escalating demand for diagnostic tools to identify health disparities and the increasing prevalence of infectious and chronic diseases are driving forces that further amplify the need for effective diagnostics, boosting the market's expansion. Additionally, technological advancements, frequent product launches, partnerships, and acquisitions by key market players are propelling the growth trajectory in North America.

Additionally, by sample type, the DNA segment accounted for the largest market share in 2022. The DNA segment has captured the largest market share, primarily driven by several influential factors. The increasing incidence of cancer cases worldwide has elevated the demand for advanced diagnostic tools, such as those involving DNA analysis, to aid in early detection and personalized treatment approaches. This surge in cancer cases has led to a heightened emphasis on understanding genetic variations and mutations that contribute to the disease, propelling the demand for DNA segment products. Furthermore, substantial research and development investments focused on studying DNA samples have played a pivotal role in driving the growth of this segment. The scientific community's intensified efforts to comprehend the genetic underpinnings of various diseases, including cancer, have fuelled the requirement for sophisticated DNA analysis tools. As a result, the DNA segment has gained prominence as an indispensable resource for gaining insights into disease mechanisms and designing targeted interventions. Also, by Products & Services, the workstation/instruments segment accounted for the highest market share in 2022 globally.

Drivers for Next Generation Sequencing (NGS) Sample Preparation Market:

The rising growth of sequencing data is driving the significant demand for diverse sample preparation protocols. As the volume of genomic and molecular data grows, researchers and clinicians are compelled to develop innovative methods to process and analyze these databases efficiently. This condition arises from the complex nature of biological samples and tailored protocols to extract high-quality genetic material, thus ensuring accurate insights from diverse biological frameworks. The development of sample preparation techniques is essential for escalating the data and enhancing the precision, reliability, and comprehensiveness of genomic analysis, eventually advancing the understanding of genetic variation, disease mechanisms, and therapeutic approaches, further propelling the market growth.

Restrain for Next Generation Sequencing (NGS) Sample Preparation Market:

The complexity and lack of widespread understanding of NSG testing procedures are expected to hinder the growth of the Next Generation Sequencing (NGS) Sample Preparation market. The intricate nature of sample preparation workflows, involving steps like DNA fragmentation, library preparation, and target enrichment, requires a profound knowledge of molecular techniques and bioinformatics analysis. Moreover, the rapid and ongoing development of NSG technologies creates barriers for laboratories aiming to implement these methods effectively. Laboratories and researchers seeking to adopt NGS must navigate deep learning, requiring specialized training, skilled professionals, and frequently third-party expertise to guarantee accurate outcomes.

Opportunities for Next Generation Sequencing (NGS) Sample Preparation Market:

Next-generation sequencing enables global scientific collaboration, such as the International Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA) project. These collaborations harness the ability of NGS to facilitate unparalleled opportunities for comprehensive genomic exploration, aiming to profile and characterize the genetic intricacies of thousands of cancer genomes spanning diverse disease categories. This collaborative approach fuels groundbreaking discoveries in understanding cancer's molecular support and establishes a robust foundation for identifying potential therapeutic targets, biomarkers, and personalized treatment approaches. The data generated from NGS allow researchers worldwide to investigate complex genomic geographies, fostering cross-disciplinary collaborations and sparking innovative insights that may change the future of oncology and beyond.

Trend for Next Generation Sequencing (NGS) Sample Preparation Market:

The emerging trend of integrating NGS with other technologies, such as microfluidics and lab-on-a-chip systems, is anticipated to transform sample preparation workflows and boost operating efficiency within the genomics landscapes. By seamlessly integrating NGS with microfluid platforms, researchers may harness the benefits of minute fluid handling, precise control, and rapid responses to simplify complex sample preparation processes. This synergy accelerated the sequencing pipeline and conserved precious samples, reduced reagent consumption, and minimized human intervention, thereby enhancing reproducibility and data accuracy. Moreover, the convergence of NGS with lab-on-a-chip systems offers portability, and high sensitivity, enabling decentralized applications, point-if-care operations, and remote fieldwork. As the trend increases, it may change the NGS geography, innovative methodologies, cost-effectiveness, and broader accessibility to high-throughput genomics across diverse research and healthcare settings, further driving the demand for Next Generation Sequencing (NGS) Sample Preparation Market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • FutureWise research report will help you understand the growth prospects, key trends, and data points affecting the market's growth.
  • A detailed review of strategies being opted by the players in this market, and a thorough market share registered by the key companies globally as well as on a regional basis.

  • To provide with an exhaustive analysis on the of Next Generation Sequencing (NGS) Sample Preparation Market By Product & Services, By Workflow, By Sample Type, By Method, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Next-Generation Sequencing (NGS) Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Global Next-Generation Sequencing (NGS) Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Next-Generation Sequencing (NGS) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Next-Generation Sequencing (NGS) Market, By Product & Services Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Workstations/Instruments
        2. Reagents and Consumables
              3. Services

  • 8.   Global Next-Generation Sequencing (NGS) Market, By Workflow Historical Analysis and Forecast 2023-2031(USD Million)
    •   1. DNA Fragmentation & Library Preparation
        2. Target Enrichment
        3. QC

  • 9.   Global Next-Generation Sequencing (NGS) Market, By Sample Historical Analysis and Forecast 2023-2031(USD Million)
    •   1. DNA
        2. RNA

  • 10.   Global Next-Generation Sequencing (NGS) Market, By Method Historical Analysis and Forecast 2023-2031 (USD Million)
    •         1. Manual Sample Preparartion
        2. Microfluidic Sample Preparation
        3. Automated Liquid Handling-based Sample Preparation

  • 11.   Global Next-Generation Sequencing (NGS) Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnostics
        2. Drug Discovery
        3. Agricultural & Animal Research
        4. Others

  • 12.  Global Next-Generation Sequencing (NGS) Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Academic Institutes & Research Centers
        2. Hospitals & Clinics
        3. Pharma & Biotech Companies
        4. Other End-users

  • 13.  North America Next-Generation Sequencing (NGS) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.  Latin America Next-Generation Sequencing (NGS) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.  Europe Next-Generation Sequencing (NGS) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Rest of Western Europe
       3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.  Asia Pacific Next-Generation Sequencing (NGS) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. Singapore
         2.4. India
         2.5. Australia and New Zealand
         2.6. ASEAN
         2.7. South Korea
         2.8. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 17.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.  Market Share Analysis and Competitive Landscape
    •      1. Global Landscape - Key Players, Revenue and Presence
           2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
           3. Global Emerging Companies
           4. North America - Market Share Analysis and Key Regional Players
           5. Europe - Market Share Analysis and Key Regional Players
           6. Asia Pacific - Market Share Analysis and Key Regional Players
           7. Global Key Player - Growth Matrix

  • 19.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •         1. Agilent Technologies, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Becton, Dickinson and Company
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Beckman Coulter (A Subsidiary of Danaher)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. F. Hoffmann-La Roche AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Illumina, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. New England Biolabs, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Nugen Technologies, Inc. (Part of Tecan Trading Ag)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Oxford Gene Technology (Part of Sysmex)
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Oxford Nanopore Technologies, Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Pacific Biosciences of California, Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Perkinelmer, Inc
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. QIAGEN N.V.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Raindance Technologies, Inc. (Part of Bio-Rad Laboratories)
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Swift Biosciences Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Thermo Fisher Scientific Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 20.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
      administrations
        5. The overall economic slowdown of the developing and developed nations

  • 21.  FutureWise SME Key Takeaway Points for Client
    •   

Related Market

Next Generation Sequencing Market

Read More

Next Generation Sequencing (NGS) Services Market

Read More

Next Generation Cancer Diagnostics Market

Read More

Next Generation Optical Biometry Devices Market

Read More
Partner

Our Clients